NATCO announces tentative approval to its ANDA for Trabectedin
According to industry sales data, Yondelis generated annual sales of $49.7 million for the twelve months ending June 2022 in the US market.
According to industry sales data, Yondelis generated annual sales of $49.7 million for the twelve months ending June 2022 in the US market.
The Supervisory Board has unanimously decided to propose Roy Jakobs as the next President and CEO of Royal Philips to its General Meeting of Shareholders.
Collaboration supports multiple discovery efforts, including vaccines
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
The card-to-cloud device was launched into the U.S. and many other markets and is designed to work without an embedded communications module.
The product will be manufactured at Lupin’s facility in Goa, India.
New deal strengthens Congenica’s presence in India
Pharmaceutical sales de-grew 18% YoY and stood at Rs. 224 crore whereas Crop Protection sales de-grew by 15% at Rs. 154 crore
Margins under pressure - Price erosion, shelf stock adjustments and inventory pare down in US biz impacted margins.
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
Subscribe To Our Newsletter & Stay Updated